Heterocyclic amides as kinase inhibitors

A compound according to Formula (I):

• wherein:
• X is O;
• Y is CH2 or CH2CH2;
• Z1 is N, CH or CR1;
• Z2 is CH or CR2;
• Z3 is N, CH or CR3;
• Z4 is CH or CR4;
• R1 is fluoro or methyl;
• one of R2 and R3 is halogen, cyano, (C1-C6)alkyl, halo(C1-C4)alkyl, (C1-C6)alkoxy, halo(C1-C4)alkoxy, hydroxyl, B(OH)2, —COOH, halo(C1-C4)alkylC(OH)2—, (C1-C4)alkoxy(C1-C4)alkoxy, (C1-C4)alkylSO2—, (C1-C4)alkylSO2NHC(O)—, (C1-C4)alkylC(O)NH—, ((C1-C4)alkyl)((C1-C4)alkyl)NC(O)—, (C1-C4)alkylOC(O)—, (C1-C4)alkylC(O)N(C1-C4)alkyl)-, (C1-C4)alkylNHC(O)—, (C1-C4)alkoxy(C2-C4)alkylNHC(O)—, (C1-C4)alkoxy(C2-C4)alkylNHC(O)NH—, (C1-C4)alkylSO2(C2-C4)alkylNHC(O)—,(C1-C4)alkylNHC(O)NH—, (C1-C4)alkylOC(O)NH—, hydroxy(C1-C4)alkylOC(O)NH—, 5-6 membered heterocycloalkyl-C(O)—, 5-6 membered heterocycloalkyl-(C1-C4)alkyl-NHC(O)—, 5-6 membered heterocycloalkyl-(C1-C4)alkoxy-, 3-6 membered cycloalkyl, 5-6 membered heteroaryl, or 5-6 membered heteroaryl-C(O)NH,
• wherein said 3-6 membered cycloalkyl, 5-6 membered heterocycloalkyl and 5-6 membered heteroaryl are optionally substituted by 1 or 2 substituents each independently selected from the group consisting of (C1-C4)alkyl and —(C1-C4)alkyl-CN;
• and the other of R2 and R3 is halogen, cyano or (C1-C6)alkyl;
• R4 is fluoro, chloro, methyl trifluoromethyl;
• R5 is H or methyl,
• A is phenyl, 5-6 membered heteroaryl, or 5-6 membered heterocycloalkyl, wherein the carbonyl moiety and L are substituted 1,3 on ring A;
• m is 0 or m is 1 and RA is (C1-C4)alkyl;
• and
• L is O, S, NH, N(CH3), CH2, CH2CH2, CH(CH3), CHF, CF2, CH2O, CH2N(CH3), CH2NH, or CH(OH);
• B is an optionally substituted (C1-C6)cycloalkyl, phenyl, 5-6 membered heteroaryl, or 5-6 membered heterocycloalkyl;
• wherein said (C3-C6)cycloalkyl, phenyl, 5-6 membered heteroaryl, or 5-6 membered heterocycloalkyl is unsubstituted or is substituted by one or two substituents each independently selected from halogen, (C1-C4)alkyl, halo(C1-C4)alkyl, (C1-C4)alkoxy, halo(C1-C4)alkoxy, nitro, and (C1-C4)alkylC(O)—;
• or the moiety -L-B is (C3-C6)alkyl, (C3-C6)alkoxy, halo(C3-C6)alkoxy, (C3-C6)alkenyl, or (C3-C6)alkenyloxy;
• or a pharmaceutically acceptable salt thereof.